Search Button - Minden Gross LLP site Twitter Button - Minden Gross LLP page LinkedIn Button - Minden Gross LLP page Instagram Button - Minden Gross LLP

145 King Street West, Suite 2200 | Toronto, Ontario | M5H 4G2 | 416 362 3711

Vaccination and Office Visitation Policy

Minden Gross LLP has implemented a vaccination and visitation policy for our office and its visitors. Read:

Holiday Closure - May 23

Please be advised our office will be closed on Monday, May 23, for Victoria Day.

News & Events

BIG DEAL: Aura Health Inc. announces Second Tranche of its Subscription Receipt Offering and Share Exchange Transaction

Apr 18, 2019

Logo - Aura Health

Aura Health Inc. (“Aura”) (CSE:BUZZ) is pleased to announce that it has closed the second tranche of its previously announced “best efforts” private placement subscription receipt offering (the “Offering”) for additional gross proceeds of $2,820,070 (the “Second Tranche Offering”), as well as a share exchange transaction with FSD Pharma Inc. (“FSD”), a licensed producer under the Cannabis Act whereby, among other things, FSD issued $3 million of FSD shares (the “FSD Shares”) to the Company in exchange for $3 million of Aura shares (the “Aura Shares”). Since the FSD Shares were issued to the Company on a private placement basis, the Company is in the process of finalizing an up to $3 million bridge facility (the “Bridge Facility”) to cover the value of the FSD Shares until they are freely tradeable. The gross proceeds of $1,919,929 raised pursuant to the closing of the first tranche of the Offering, the gross proceeds of $2,820,070 raised pursuant to the Second Tranche Offering, the $3 million of FSD Shares issued to Aura in connection with the Share Exchange, and the Bridge Facility will generate $7,740,000 for the Company and will provide the Company with the funds required to close the proposed acquisition of an 80% equity interest in Pharmadrug Production GmbH, previously announced in a press release dated January 25, 2019.

Minden Gross LLP acted for Aura with a team lead by Andrew Elbaz (Partner, Securities & Capital Markets), David Judson (​Partner, Securities & Capital Markets), and Alexander Katznelson (Associate, Securities & Capital Markets).

Read the press release here:

Photo: Andrew Elbaz - Lawyer, Securities and Capital MarketsImage: David Judson, Business Law LawyerImage: Alexander Katznelson, Business Law Lawyer